Boxer Capital, LLC Syndax Pharmaceuticals Inc Transaction History

Boxer Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$15.23 - $22.47 $34.8 Million - $51.4 Million	-2,287,782 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$8.94 - $20.98 $14 Million - $32.8 Million	1,562,000 Added 215.22%	2,287,782 $33.9 Million
Q1 2020 May 15, 2020	BUY	$6.65 - $12.03 $3.16 Million - $5.72 Million	475,782 Added 190.31%	725,782 $7.96 Million
Q4 2019 Feb 14, 2020	SELL	$5.43 - $9.22 $814,500 - $1.38 Million	-150,000 Reduced 37.5%	250,000 $2.2 Million
Q3 2019 Nov 14, 2019	BUY	$7.47 - $10.76 $2.99 Million - $4.3 Million	400,000 New	400,000 $2.99 Million
Q4 2018 Feb 14, 2019	SELL	$3.6 - $8.42 $360,000 - $842,000	-100,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$10.9 - $12.73 $1.09 Million - $1.27 Million	100,000	100,000 $1.17 Million

227

88.3M

1.01M

692K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $895M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.